94-24597. Power Authority of the State of New York; Notice of Consideration of Issuance of Amendment to Facility Operating License, Proposed No Significant Hazards Consideration Determination, and Opportunity for a Hearing  

  • [Federal Register Volume 59, Number 192 (Wednesday, October 5, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-24597]
    
    
    [[Page Unknown]]
    
    [Federal Register: October 5, 1994]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    NUCLEAR REGULATORY COMMISSION
    
    [Docket No. 50-286]
    
     
    
    Power Authority of the State of New York; Notice of Consideration 
    of Issuance of Amendment to Facility Operating License, Proposed No 
    Significant Hazards Consideration Determination, and Opportunity for a 
    Hearing
    
        The U.S. Nuclear Regulatory Commission (the Commission) is 
    considering issuance of amendment to Facility Operating License No. 
    DRP-64, issued to the Power Authority of the State of New York (the 
    licensee), for operation of the Indian Point Nuclear Generating Unit 
    No. 3 (Indian Point 3) located in Westchester County, New York.
        The proposed amendment would revise Section 4.4 of the Indian Point 
    Nuclear Generating Unit No. 3 Power Plant Technical Specifications. 
    Specifically, TS 4.4.E.1 would be revised to allow a one-time extension 
    to the 30-month interval requirement for leak rate testing of Residual 
    Heat Removal (RHR) containment isolation valves AC-732, AC-741, AC-MOV-
    743, AC-MOV-744, and AC-MOV-1870. A one-time schedular exemption from 
    plant specific requirements associated with 10 CFR Part 50, Appendix J, 
    Type C testing (local leak rate test) for the above listed RHR 
    containment isolation valves will be processed separately. This one-
    time extension for leak rate testing of the RHR valves would defer the 
    leak rate testing until the next refueling outage, when the RHR system 
    can be removed from service as required by current procedures.
        Before issuance of the proposed license amendment, the Commission 
    will have made findings required by the Atomic Energy Act of 1954, as 
    amended (the Act) and the Commission's regulations.
        The Commission has made a proposed determination that the amendment 
    request involves no significant hazards consideration. Under the 
    Commission's regulations in 10 CFR 50.92, this means that operation of 
    the facilities in accordance with the proposed amendment would not (1) 
    involve a significant increase in the probability or consequences of an 
    accident previously evaluated; or (2) create the possibility of a new 
    or different kind of accident from any accident previously evaluated; 
    or (3) involve a significant reduction in a margin of safety. As 
    required by 10 CFR 50.91(a), the licensee has provided its analysis of 
    the issue of no significant hazards consideration, which is presented 
    below:
    
        Consistent with the criteria of 10 CFR 50.92, the enclosed 
    application is judged to involve no significant hazards based on the 
    following information:
        1. Does the proposed license amendment involve a significant 
    increase in the probability or consequences of an accident 
    previously evaluated?
        Response: The proposed license amendment does not involve a 
    significant increase in the probability or consequences of an 
    accident previously evaluated. The proposed change is limited to a 
    one-time extension of the containment isolation valve leak rate test 
    for RHR valves AC-732, AC-741, AC-MOV-743, AC-MOV-744, and AC-MOV-
    1870. The change does not introduce any new modes of plant 
    operation, make any physical changes, or alter any operational 
    setpoints. Therefore, the change does not degrade the performance of 
    any safety system assumed to function in the accident analysis. 
    There is reasonable assurance that the extension will not result in 
    a significant increase in valve leakage considering that a review of 
    containment isolation valve leakage rate test results through 1990 
    showed that all leakage failures, except for one valve which was 
    replaced in 1990, were random and nonrecurring. Additionally, each 
    of the three RHR lines associated with valves AC-732, AC-741, AC-
    MOV-743, AC-MOV-744, and AC-MOV-1870 has redundant isolation 
    barriers and is supplied by the IVSWS [isolation valve seal water 
    system] which would minimize any leakage past the isolation 
    barriers. Further, due to the periodic surveillance that ensures 
    that leakage from RHR components located outside containment does 
    not exceed two gallons per hour, even if significant leakage past 
    the RHR containment isolation valves occurred, this would not 
    significantly affect off-site exposures.
        2. Does the proposed license amendment create the possibility of 
    a new or different kind of accident from any accident previously 
    evaluated?
        Response: The proposed license amendment does not create the 
    possibility of a new or different kind of accident from any accident 
    previously evaluated. The proposed change does not introduce new 
    accident initiators or failure mechanisms since the change does not 
    alter the physical characteristics of any plant system or component. 
    The change is limited to a one-time extension to the leak rate test 
    interval for RHR valves AC-732, AC-741, AC-MOV-743, AC-MOV-744, and 
    AC-MOV-1870.
        3. Does the proposed amendment involve a significant reduction 
    in a margin of safety?
        Response: The proposed amendment does not involve a significant 
    reduction in a margin of safety. There is reasonable assurance that 
    the extension will not result in a significant increase in valve 
    leakage since a review of containment isolation valve leakage rate 
    test results through 1990 showed that all leakage failures, except 
    for one valve which was replaced in 1990, were random and 
    nonrecurring. Additionally, each of the three RHR lines associated 
    with valves AC-732, AC-741, AC-MOV-743, AC-MOV-744, and AC-MOV-1870 
    has redundant isolation barriers. Further, due to the periodic 
    surveillance that ensures that leakage from RHR components located 
    outside containment does not exceed two gallons per hour, even if 
    significant leakage past the RHR containment isolation valves 
    occurred, this would not significantly affect off-site exposures.
    
        The NRC staff had reviewed the licensee's analysis and, based on 
    this review, it appears that the three standards of 10 CFR 50.92(c) are 
    satisfied. Therefore, the NRC staff proposes to determine that the 
    amendment request involves no significant hazards consideration.
        The Commission is seeking public comments on this proposed 
    determination. Any comments received within 30 days after the date of 
    publication of this notice will be considered in making any final 
    determination.
        Normally, the Commission will not issue the amendments until the 
    expiration of the 30-day notice period. However, should circumstances 
    change during the notice period such that failure to act in a timely 
    way would result, for example, in derating or shutdown of the 
    facilities, the Commission may issue the license amendments before the 
    expiration of the 30-day notice period, provided that its final 
    determination is that the amendments involve no significant hazards 
    consideration. The final determination will consider all public and 
    State comments received. Should the Commission take this action, it 
    will publish in the Federal Register a notice of issuance and provide 
    for opportunity for a hearing after issuance. The Commission expects 
    that the need to take this action will occur very infrequently.
        Written comments may be submitted by mail to the Rules Review and 
    Directives Branch, Division of Freedom of Information and Publications 
    Services, Office of Administration, U.S. Nuclear Regulatory Commission, 
    Washington, DC 20555, and should cite the publication date and page 
    number of this Federal Register notice. Written comments may also be 
    delivered to room 6D22, Two White Flint North, 11545 Rockville Pike, 
    Rockville, Maryland, from 7:30 a.m. to 4:15 p.m. Federal workdays. 
    Copies of written comments received may be examined at the NRC Public 
    Document Room, the Gelman Building, 2120 L Street, NW., Washington, DC 
    20555.
        The filing of requests for hearing and petitions for leave to 
    intervene is discussed below.
        By November 4, 1994, the licensee may file a request for a hearing 
    with respect to issuance of the amendments to the subject facility 
    operating licenses and any person whose interest may be affected by 
    this proceeding and who wishes to participate as a party in the 
    proceeding must file a written request for a hearing and a petition for 
    leave to intervene. Requests for a hearing and a petition for leave to 
    intervene shall be filed in accordance with the Commission's ``Rules of 
    Practice for Domestic Licensing Proceedings'' in 10 CFR part 2. 
    Interested persons should consult a current copy of 10 CFR 2.714 which 
    is available at the Commission's Public Document Room, the Gelman 
    Building, 2120 L Street, NW., Washington, DC 20555 and at the local 
    public document room located at the White Flint Plains Public Library, 
    100 Martine Avenue, White Plains, New York 10601. If a request for a 
    hearing or petition for leave to intervene is filed by the above date, 
    the Commission or an Atomic Safety and Licensing Board, designated by 
    the Commission or by the Chairman of the Atomic Safety and Licensing 
    Board Panel, will rule on the request and/or petition; and the 
    Secretary of the designated Atomic Safety and Licensing Board will 
    issue a notice of hearing or an appropriate order.
        As required by 10 CFR 2.714, a petition for leave to intervene 
    shall set forth with particularity the interest of the petitioner in 
    the proceeding, and how that interest may be affected by the results of 
    the proceeding. The petition should specifically explain the reasons 
    why intervention should be permitted with particular reference to the 
    following factors: (1) The nature of the petitioner's right under the 
    Act to be made party to the proceeding; (2) the nature and extent of 
    the petitioner's property, financial, or other interest in the 
    proceeding; and (3) the possible effect of any order which may be 
    entered in the proceeding on the petitioner's interest. The petition 
    should also identify the specific aspect(s) of the subject matter of 
    the proceeding as to which petitioner wishes to intervene. Any person 
    who has filed a petition for leave to intervene or who has been 
    admitted as a party may amend the petition without requesting leave of 
    the Board up to 15 days prior to the first perhearing conference 
    scheduled in the proceeding, but such an amended petition must satisfy 
    the specificity requirements described above.
        Not later than 15 days prior to the first prehearing conference 
    scheduled in the proceeding, a petitioner shall file a supplement to 
    the petition to intervene which must include a list of the contentions 
    which are sought to be litigated in the matter. Each contention must 
    consist of a specific statement of the issue of law or fact to be 
    raised or controverted. In addition, the petitioner shall provide a 
    brief explanation of the bases of the contention and a concise 
    statement of the alleged facts or expert opinion which support the 
    contention and on which the petitioner intends to rely in proving the 
    contention at the hearing. The petitioner must also provide references 
    to those specific sources and documents of which the petitioner is 
    aware and on which the petitioner intends to rely to establish those 
    facts or expert opinion. The petitioner must provide sufficient 
    information to show that a genuine dispute exists with the applicant on 
    a material issue of law or fact. Contentions shall be limited to 
    matters within the scope of the amendment under consideration. The 
    contention must be one which, if proven, would entitle the petitioner 
    to relief. A petitioner who fails to file such a supplement which 
    satisfies these requirements with respect to at least one contention 
    will not be permitted to participate as a party.
        Those permitted to intervene become parties to the proceeding, 
    subject to any limitations in the order granting leave to intervene, 
    and have the opportunity to participate fully in the conduct of the 
    hearing, including the opportunity to present evidence and cross-
    examine witnesses.
        If a hearing is requested, the Commission will make a final 
    determination on the issue of no significant hazards consideration. The 
    final determination will serve to decide when the hearing is held.
        If the final determination is that the amendment request involves 
    no significant hazards consideration, the Commission may issue the 
    amendment and make it immediately effective, notwithstanding the 
    request for a hearing. Any hearing held would take place after issuance 
    of the amendment.
        If the final determination is that the amendment request involves a 
    significant hazards consideration, any hearing held would take place 
    before the issuance of any amendments.
        A request for a hearing or a petition for leave to intervene must 
    be filed with the Secretary of the Commission, U.S. Nuclear Regulatory 
    Commission, Washington, DC 20555, Attention: Docketing and Services 
    Branch, or may be delivered to the Commission's Public Document Room, 
    the Gelman Building, 2120 L Street, NW., Washington, DC 20555, by the 
    above date. Where petitions are filed during the last 10 days of the 
    notice period, it is requested that the petitioner promptly so inform 
    the Commission by a toll-free telephone call to Western Union at 1-
    (800) 248-5100 (in Missouri 1-(800) 342-6700). The Western Union 
    operator should be given Datagram Identification Number N1023 and the 
    following message addressed to Michael J. Case: petitioner's name and 
    telephone number, date petition was mailed, plant name, and publication 
    date and page number of this Federal Register notice. A copy of the 
    petition should also be sent to the Office of the General Counsel, U.S. 
    Nuclear Regulatory Commission, Washington, DC 20555, and to Mr. Charles 
    M. Pratt, 10 Columbus Circle, New York, New York 10019, attorney for 
    the licensee.
        Nontimely filings of petitions for leave to intervene, amended 
    petitions, supplemental petitions and/or requests for hearing will not 
    be entertained absent a determination by the Commission, the presiding 
    officer or the presiding Atomic Safety and Licensing Board that the 
    petition and/or request should be granted based upon a balancing of the 
    factors specified in 10 CFR 2.714(a)(1)(i)-(v) and 2.714(d).
        For further details with respect to this action, see the 
    application for amendment dated September 29, 1994, which is available 
    for public inspection at the Commission's Public Document Room, the 
    Gelman Building, 2120 L Street, NW., Washington, DC 20555 and at the 
    local public document room located at the White Plains Public Library, 
    100 Martine Avenue, White Plains, New York 10601.
    
        Dated at Rockville, Maryland, this 29th day of September 1994.
    
        For the Nuclear Regulatory Commission.
    Michael J. Case,
    Acting Director, Project Directorate I-1, Division of Reactor 
    Projects--I/II, Office of Nuclear Reactor Regulation.
    [FR Doc. 94-24597 Filed 10-4-94; 8:45 am]
    BILLING CODE 7590-01-M
    
    
    

Document Information

Published:
10/05/1994
Department:
Nuclear Regulatory Commission
Entry Type:
Uncategorized Document
Document Number:
94-24597
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: October 5, 1994, Docket No. 50-286